论文部分内容阅读
很少Paolo Verdecchia等研究特殊药物方案是否可以解释高血压或高危患者应用血管紧张素转换酶抑制剂(ACEIs)和钙通道阻滞剂(CCBs)防止冠心病(CHD)和脑卒中。Paolo Verdecchia等摘录28项比较ACEIs或CCBs加用利尿剂、β-阻滞剂或安慰剂的关于CHD和脑卒中后果试验的总结统计,其中
Few Paolo Verdecchia et al. Studies of specific drug regimens may explain the use of angiotensin-converting enzyme inhibitors (ACEIs) and calcium channel blockers (CCBs) in the prevention of coronary heart disease (CHD) and stroke in hypertensive or at-risk patients. Paolo Verdecchia et al. Summarized 28 summary statistics of CHD and stroke outcome trials comparing ACEIs or CCBs with diuretics, beta-blockers or placebo, with